science

Covaxin 50% effective against COVID shows 1st real-world study published in Lancent

Covaxin 50% effective against COVID shows 1st real-world study published in Lancent

The first real-world assessment of the effectiveness of Covaxin against symptomatic COVID-19 at least 14 days after second dose was 50%, while it was 46% at least 28 days after second dose and 57% at least 42 days after second dose. The study published in The Lancet Infectious Diseases assessed 2,714 AIIMS, Delhi workers between April 15 and May 15..

science 2021-11-24 Inshorts